McGill scientists unveil “Alenomers,” a new molecular platform that could rival antibodies

Montreal, May 6, 2026 – Researchers from McGill University have introduced a groundbreaking new class of molecules that could significantly reshape drug discovery and development. The technology,...

• Read more about McGill scientists unveil “Alenomers,” a new molecular platform that could rival antibodies